SEC Tracker
Get the app

Editas Medicine EDIT

Editas Medicine: reports quarterly results

Form
8-K
Filed
Importance
Routine
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Editas Medicine files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float under $300M, nearest public float first, as each company reports it on its annual report cover.

  1. Allogene Therapeutics ALLO public float $184M, Jun 30, 2025
  2. Cardiff Oncology CRDF public float $205M, Jun 30, 2025
  3. Inhibrx Biosciences INBX public float $175M, Jun 30, 2025
  4. Monte Rosa Therapeutics GLUE public float $212M, Jun 30, 2025
  5. Century Therapeutics IPSC public float $213M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.